You're reading the free version. Trader adds the live tape and alerts.
Start tracking
MNPR Exercise Disclosure
Robinson Chandler · SEC Form 4 · Filed Oct 2, 2026
Exercise
Calculated transaction value
$0
Robinson Chandler Chief Executive Officer
MNPR
Monopar Therapeutics
MNPR
Transaction date
Sep 30, 2026
Public filing date
Oct 2, 2026
Filing lag
Filed 2 days later
MNPR daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Restricted Stock Unit on Common Stock
- Quantity / price
- 9,801 shares @ $0
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-031925
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$346.09K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monopar Therapeutics MNPR | Exercise | Sep 30, 2026 | Not reported |
| Monopar Therapeutics MNPR | Disposition | Sep 30, 2026 | $346.09K |
| Monopar Therapeutics MNPR Current | Exercise | Sep 30, 2026 | $0 |